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Background
Diabetic ketoacidosis as a complication of L asparaginase
therapy in children with acute leukemia is rare. We report
a patient with acute lymphoblastic leukemia who devel-
oped diabetic ketoacidosis while on treatment with
L-asparaginase.
Case
E.C, 10 years old female brought to the ER due abdominal
pain. Patient is a diagnosed case of B-Cell Acute Lympho-
blastic Leukemia (ALL) thru clinical symptoms, laboratory
work-ups and flow cytometry since 2 months prior to her
present admission. She has been receiving 8 doses of
L-asparaginase (leunase) and Prednisone (60mg/day for a
week then 40mg/day for 3 weeks) for almost one month
before this recent admission. One week prior to hospitali-
zation, the patient had nocturia (2-3x/night), polyuria and
polydipsia. On the day of admission, she had sudden onset
difficulty of breathing associated with severe abdominal
pain and vomiting. She came in non-ambulatory, in cardi-
orespiratory distress with BP: 100/70mmHg, HR: 150/min,
RR: 60/min, Temp: 37.3°C. Pertinent physical exam
showed signs of dehydration with abdominal tenderness,
and signs of circulatory compromise. Fluid resuscitation
was immediately instituted. The initial assessment at the
ER was pancreatitis but the serum amylase and lipase were
normal. Other lab work-ups showed blood glucose of 26.8
mmol/L (NV:3.08-7.92), sodium at 115 mmol/L(NV:132-
143), potassium of 3.3, Chloride at 88mmol/L (NV: 98-
116). Blood gas showed ph of 7.1, a pCO2: 50, HCO3 at
3.7, and a base deficit of -22.5mmol/L. Urinalysis showed
+4 of glucose and +3 of ketones. The patient was then
managed as a case of DKA and fluid resuscitation was
continued and insulin drip was started. The haemoglobin
A1c level at diagnosis was 11.4% but the C-peptide was
normal. Patient condition improved and was discharged
with insulin injection. The insulin was discontinued after
completion of her induction phase and with normalization
of blood glucose.
Conclusion
Early recognition of the precipitating factors for DKA is
important to prevent L-asparaginase fatal consequences,
and the leukemic process itself maybe considered as one
of the predisposing factors.
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